In burn‐ALI mice with secondary pneumonia, CuMPBA restored lung architecture, suppress TNF‐α/IL‐1β/IL‐6 levels, and modulated inflammatory pathways by activating Nrf2 while inhibiting NF‐κB. Here, NFKB1 is linked to pneumonia.